V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003688 | 300002581 | 1.58 | 73.6 | Curative (C) | 2015-10-27 | 2015-11-14 | Cetuximab 7 day (Cycle 1) | N | Y | 300016471 | CETUXIMAB |
| 300003689 | 300002581 | 1.73 | 99.4 | Neo-adjuvant (N) | 2014-10-22 | 2014-11-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016471 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003690 | 300002582 | null | null | Palliative (P) | 2016-06-08 | 2016-06-16 | CISPLATIN + FLUOROURACIL | null | N | 300016480 | CISPLATIN + FLUOROURACIL |
| 300003691 | 300002583 | null | 83.8 | Curative (C) | 2016-05-12 | 2016-06-02 | Cetuximab 7 day (Cycle 1) | N | N | 300016481 | CETUXIMAB |
| 300003692 | 300002584 | 1.57 | 82.3 | Neo-adjuvant (N) | 2016-04-26 | 2016-04-30 | Cisplatin +Fluorouracil (3 wk) | N | null | 300016483 | CISPLATIN + FLUOROURACIL |
| 300003693 | 300002585 | 1.68 | 82.9 | null | 2013-07-19 | 2013-08-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016502 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003694 | 300002586 | 1.45 | null | Curative (C) | 2013-10-10 | 2013-10-25 | CETUXIMAB + RT | 02 | Y | 300016503 | CETUXIMAB + RT |
| 300003695 | 300002587 | 1.6 | 82.2 | null | 2014-01-23 | 2014-01-29 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016504 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003696 | 300002587 | 1.66 | 62.8 | Neo-adjuvant (N) | 2014-11-02 | 2014-11-02 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016504 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003697 | 300002588 | 1.58 | 74.9 | Not known (9) | null | 2013-04-12 | CETUXIMAB + RT | N | Y | 300016508 | CETUXIMAB + RT |
| 300003698 | 300002588 | 1.67 | 44 | Not known (9) | 2015-12-18 | 2015-12-31 | Trial Unspecified | 2 | N | 300016508 | TRIAL |
| 300003699 | 300002589 | 1.6 | 69.1 | null | 2015-10-23 | 2015-10-30 | Capecitabine | 02 | null | 300016511 | CAPECITABINE |
| 300003700 | 300002590 | 1.74 | 109.8 | Neo-adjuvant (N) | 2013-07-11 | 2013-07-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300016512 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003701 | 300002591 | 1.7 | 73 | Curative (C) | 2014-03-04 | 2014-03-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016513 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003702 | 300002592 | 1.54 | 83.7 | Neo-adjuvant (N) | 2016-02-14 | 2016-03-06 | CISPLATIN + FLUOROURACIL | N | N | 300016517 | CISPLATIN + FLUOROURACIL |
| 300003703 | 300005981 | 1.64 | 120 | Adjuvant (A) | 2014-04-26 | 2014-05-15 | Capecitabine | N | N | 300016522 | CAPECITABINE |
| 300003704 | 300002593 | null | 91 | 2 | 2013-05-09 | 2013-05-11 | CISPLATIN + FLUOROURACIL | N | N | 300016523 | CISPLATIN + FLUOROURACIL |
| 300003705 | 300002594 | 1.73 | 80.3 | Palliative (P) | 2013-06-30 | 2013-06-30 | Capecitabine | N | N | 300016525 | CAPECITABINE |
| 300003706 | 300002595 | 1.45 | null | null | 2017-12-25 | 2018-01-03 | CISPLATIN + FLUOROURACIL | 02 | N | 300016533 | CISPLATIN + FLUOROURACIL |
| 300003707 | 300002595 | 1.86 | 115.35 | null | 2015-07-08 | 2015-07-15 | Trial Unspecified | N | Y | 300016533 | TRIAL |
| 300003708 | 300002596 | 1.65 | 61 | Palliative (P) | 2017-04-30 | 2017-05-14 | CETUXIMAB | N | N | 300016539 | CETUXIMAB |
| 300003709 | 300002597 | 1.76 | 85.5 | Curative (C) | 2015-04-18 | 2015-04-26 | Trial Unspecified | N | N | 300016542 | TRIAL |
| 300003710 | 300002597 | 1.71 | 45 | null | 2018-05-31 | 2018-10-03 | CISPLATIN + FLUOROURACIL | N | N | 300016542 | CISPLATIN + FLUOROURACIL |
| 300003711 | 300002598 | 1.73 | 55 | Curative (C) | 2014-04-18 | 2014-05-07 | CETUXIMAB + RT | N | Y | 300016548 | CETUXIMAB + RT |
| 300003712 | 300002599 | null | null | Palliative (P) | 2015-08-26 | 2015-09-16 | Trial Unspecified | N | N | 300016555 | TRIAL |
| 300003713 | 300002600 | 1.65 | 69.4 | Neo-adjuvant (N) | null | 2013-04-25 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300016556 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003714 | 300002601 | 1.68 | 51.6 | Adjuvant (A) | 2016-03-08 | 2016-03-08 | Capecitabine | 02 | N | 300016558 | CAPECITABINE |
| 300003715 | 300002602 | 1.72 | 80 | Palliative (P) | 2016-11-08 | 2016-11-13 | CISPLATIN + FLUOROURACIL | N | N | 300016562 | CISPLATIN + FLUOROURACIL |
| 300003716 | 300002603 | 1.49 | null | Adjuvant (A) | 2017-06-02 | 2017-06-15 | CETUXIMAB + RT | Y | Y | 300016563 | CETUXIMAB + RT |
| 300003717 | 300002604 | 1.67 | 63.3 | Palliative (P) | 2013-04-07 | 2013-04-21 | Cisplatin + Docetaxel +Fluorouracil | null | N | 300016570 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003718 | 300002605 | 1.69 | 121 | Neo-adjuvant (N) | 2018-01-08 | 2018-01-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 300016575 | CISPLATIN + FLUOROURACIL |
| 300003720 | 300005984 | 1.83 | 56.2 | Curative (C) | 2017-12-11 | 2017-12-24 | Trial Unspecified | N | Y | 300016580 | TRIAL |
| 300003721 | 300005984 | 1.76 | 75 | Neo-adjuvant (N) | 2016-01-10 | 2016-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016580 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003722 | 300007961 | 1.69 | 89 | Neo-adjuvant (N) | 2016-07-12 | 2016-07-21 | Cisplatin + Docetaxel +Fluorouracil | null | N | 300016586 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003723 | 300002607 | 1.58 | 75.5 | Palliative (P) | 2013-04-28 | 2013-05-01 | Trial Unspecified | 02 | null | 300016588 | TRIAL |
| 300003724 | 300002608 | 1.53 | 74.5 | Neo-adjuvant (N) | 2015-07-26 | 2015-07-29 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016591 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003725 | 300002609 | null | null | Neo-adjuvant (N) | null | 2016-02-22 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300016596 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003726 | 300002610 | 1.62 | 59.6 | Neo-adjuvant (N) | 2017-08-27 | 2017-09-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016598 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003727 | 300002610 | 1.6 | 89.6 | null | 2015-07-07 | 2015-07-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300016598 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003728 | 300002610 | 1.84 | 79 | Palliative (P) | 2018-05-30 | 2018-09-09 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016598 | CARBOPLATIN + PACLITAXEL |
| 300003729 | 300002611 | 1.52 | 78 | Curative (C) | null | 2013-03-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016605 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003730 | 300002612 | 1.7 | 68 | Curative (C) | 2014-05-17 | 2014-06-01 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016607 | CETUXIMAB |
| 300003731 | 300002612 | 1.46 | 88.3 | Curative (C) | 2014-07-21 | 2014-07-22 | CETUXIMAB | 02 | Y | 300016607 | CETUXIMAB |
| 300003732 | 300002613 | 1.5 | 84 | Curative (C) | 2013-04-20 | 2013-05-16 | CETUXIMAB | N | Y | 300016621 | CETUXIMAB |
| 300003733 | 300002614 | 1.59 | 69.3 | null | 2013-09-03 | 2013-09-13 | CISPLATIN + FLUOROURACIL | 02 | N | 300016624 | CISPLATIN + FLUOROURACIL |
| 300003734 | 300002615 | 1.59 | 95.6 | Neo-adjuvant (N) | 2017-02-16 | 2017-02-18 | CISPLATIN + FLUOROURACIL | N | N | 300016626 | CISPLATIN + FLUOROURACIL |
| 300003735 | 300002616 | 1.62 | 75 | Neo-adjuvant (N) | 2013-03-01 | 2013-03-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016628 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003736 | 300002617 | 1.54 | 88 | Neo-adjuvant (N) | 2014-01-23 | 2014-02-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016630 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003737 | 300002618 | 1.53 | 108 | Not known (9) | null | 2013-04-27 | CISPLATIN + FLUOROURACIL | Y | N | 300016632 | CISPLATIN + FLUOROURACIL |
| 300003738 | 300002619 | 1.74 | 77 | Palliative (P) | 2018-05-02 | 2018-05-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300016634 | CARBOPLATIN + PACLITAXEL |